The MPO Study: Just a European HEMO Study or Something Very Different?-Reference-Cited by-同舟云学术

The MPO Study: Just a European HEMO Study or Something Very Different?

Published:2008 Issue:1 Volume:26 Page:100-104
ISSN:0253-5068
Container-title:Blood Purification
language:en
Short-container-title:Blood Purif

Author:

Locatelli Francesco,Gauly Adelheid,Czekalski Stanislaw,Hannedouche Thierry,Jacobson Stefan H.,Loureiro Alfredo,Martin-Malo Alejandro,Papadimitriou Menelaos,Passlick-Deetjen Jutta,Ronco Claudio,Vanholder Raymond,Wizemann Volker

Publisher

S. Karger AG

Subject

Nephrology,Hematology,General Medicine

Reference28 articles.

1. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters

2. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients

3. Clinical manifestations of AB‐amyloidosis: effects of biocompatibility and flux

4. Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis

5. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood Purification for the Treatment of Chronic Kidney Disease-associated Pruritus;Integrative Medicine in Nephrology and Andrology;2024-04-23

2. Switching from high‐flux dialysis to hemodiafiltration: Cost‐consequences for patients, providers, and payers;Seminars in Dialysis;2022-03-17

3. Informed decision-making in delivery of dialysis: combining clinical outcomes with sustainability;Clinical Kidney Journal;2021-12

4. Flummoxed by flux: the indeterminate principles of haemodialysis;Clinical Kidney Journal;2021-12

5. The membrane perspective of uraemic toxins: which ones should, or can, be removed?;Clinical Kidney Journal;2021-12